Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Key Market Size Shifts in the Nerve Growth Factor Market: A Historical Perspective and beyond
There has been a substantial expansion in the nerve growth factor market size in the last few years. The market is predicted to grow from $1.11 billion in 2024 to $1.19 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%.
The historic growth can be associated with the increasing cases of traumatic brain injuries, the growing occurrence of neurodegenerative diseases, an uptick in research and development investments, rising knowledge of nerve regeneration therapies, and the increasing rate of peripheral neuropathy.
Expectations are high for the nerve growth factor market size to experience considerable growth in the upcoming years. With a projected value of $1.59 billion by 2029 and a compound annual growth rate (CAGR) of 7.6%, this surge over the forecast period can be traced back to rising demand for biopharmaceuticals, an increase in autoimmune neurological disorders, a renewed focus on neuroinflammation research, higher investment in AI-powered drug discovery, and growing consumer desire for NGF-centric therapies.
The period of prediction also points towards trends such as progress in biotechnology, individualized medicine strategies, innovation in drug delivery systems, regulatory clearances, and the development of nerve growth factor (NGF) antibodies.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What’s Driving the Continued Growth of the Global Nerve Growth Factor Market?
The rising cases of neurological illnesses are predicted to boost the expansion of the nerve growth factor market. Neurological disorders signify health issues impacting the brain, spinal cord, and nerves resulting from structural, biochemical, or electrical issues.
The escalating prevalence of such disorders is attributed to an aging population and advancements in diagnostic technology. Substantial progress in diagnostic technology enhances the detection and recording of these disorders, contributing to increased recorded incidence rates.
The nerve growth factor (NGF) is instrumental in maintaining, preserving, and regenerating neurons, hence it’s a pivotal factor in combating the incidence of neurological disorders by encouraging neural repair and possibly decelerating disease progression. For example, as reported by the Australian Institute of Health and Welfare, an Australian government-owned agency, in September 2024, dementia (a neurological disorder) cases in Australia are expected to surge from around 411,100 in 2023 to 849,300 by 2058.
As such, the increasing cases of neurological disorders are fuelling the expansion of the nerve growth factor market.
Top Revenue-Generating Segments in the Nerve Growth Factor Market
The nerve growth factor market covered in this report is segmented –
1) By Type: Alpha-Nerve Growth Factor (NGF), Beta-Nerve Growth Factor (NGF), Gamma-Nerve Growth Factor (NGF), Other Types
2) By Agents: Cenegermin, Other Agents
3) By Indication: Neurodegenerative Disorders, Spinal Cord Injuries, Eye Disorders, Epithelial Diseases, Tissue Healing, Other Indications
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Alpha-Nerve Growth Factor (a-NGF): Natural Alpha-NGF, Recombinant Alpha-NGF, Synthetic Alpha-NGF, Alpha-NGF For Research Applications
2) By Beta-Nerve Growth Factor (ß-NGF): Human Beta-NGF, Animal-Derived Beta-NGF, Recombinant Beta-NGF, Therapeutic Beta-NGF, Research-Grade Beta-NGF
3) By Gamma-Nerve Growth Factor (?-NGF): Natural Gamma-NGF, Recombinant Gamma-NGF, Synthetic Gamma-NGF, Gamma-NGF for Neurodegenerative Research
4) Other Types: Hybrid NGF Molecules, NGF Mimetics, NGF Gene Therapy-Based Products, NGF-Infused Biomaterials
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
Which Trends Will Guide the Development Path of the Nerve Growth Factor Industry?
Key players in the nerve growth factor market are concentrating their efforts on creating cutting-edge products, such as nerve growth factor (NGF) monoclonal antibodies that curb NGF, with the goal of delivering efficient pain alleviation. NGF monoclonal antibodies are a type of biopharmaceutical that seeks out and neutralizes NGF, preventing its interaction with receptors, thereby decreasing both pain and inflammation in the nerves.
They play a crucial role in managing pain signals and ensuring the longevity of nerve cells. A notable example occurred in February 2022 when Akeso, Inc., a biopharmaceutical firm from China, launched AK115.
This humanized IgG1 monoclonal antibody earned the approval of China’s National Medical Products Administration to commence clinical trials targeting pain management, including pain caused by cancer. AK115 is intended to prevent NGF from interacting with its receptors, providing pain relief, superior safety over the long term, non-dependence, and heightened efficacy, particularly for cancer patients resistant to opioids.
This innovative painkiller is designed to offer enduring, non-addictive pain management, particularly benefiting opioid-resistant cancer patients by enhancing their overall quality of life.
How Are Different Regions Contributing to the Nerve Growth Factor Market’s Growth?
Asia-Pacific was the largest region in the nerve growth factor market in 2024. The regions covered in the nerve growth factor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Which Firms Are Setting the Benchmark in the Global Nerve Growth Factor Market?
Major companies operating in the nerve growth factor market are Pfizer Inc., AstraZeneca Plc, Eli Lilly & Company, Teva Pharmaceutical Industries, Regeneron Pharmaceuticals Inc., Genetech, Dompé farmaceutici S.p.A., Promega Corporation, Akeso Inc, CUSABIO TECHNOLOGY LLC, Staidson Beijing BioPharmaceuticals, Biocare Medical LLC, Beike Biotechnology, Enzo Life Sciences Inc., Genexis Biotech Pvt. Ltd., Mimetogen Pharmaceuticals, Alomone Labs, MimeTech Srl, Herantis Pharma, Prospec-Tany Technogene Ltd., PainCeptor Pharma
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=22070
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
